BD Venture

BD Venture Limited, established in 2012 and based in Dhaka, Bangladesh, is a venture capital firm dedicated to supporting innovative startups and entrepreneurs across various sectors. It aims to promote seed, early, and growth-stage enterprises by providing investment, consultancy, and other essential services. BD Venture is particularly focused on addressing the unique challenges faced by entrepreneurs who may struggle to access traditional financing options. By leveraging the expertise of its leadership, the firm tailors its approach to meet the specific needs of each venture, fostering an environment conducive to growth and expansion.

Sohel Ahamed

Analyst

Kazi Ayesha Akter

Analyst

Robiul Islam

Analyst

Md Tazul I

Investor

S.M Shaharia Mojumder

Analyst

7 past transactions

E-Desh

Series B in 2021
E-Desh is an E-Commerce Logistics Company that provides integrated logistic solutions with experience, capabilities, functional expertise, technological embedment.

Esho Shikhi

Pre Seed Round in 2019
Eshosikhi.com is an one stop online platform providing students with 360 degree solution.Students of Bangladesh can take preparation on K12 education, university entrance exam and job preparation in this platform.

Beetles

Seed Round in 2019
Beetles is an ISO 27001 certified cybersecurity consultancy focused on offensive security. The firm specializes in manual penetration testing assessments, simulating real-world attack scenarios on applications, APIs, network and cloud infrastructures, and devices. By employing skilled ethical hackers, Beetles offers agile and efficient Manual PenTests that can easily integrate with any development process. Additionally, the company provides PenTest-as-a-Service (PTaaS), which ensures continuous security coverage through a structured approach and collaboration with clients' internal teams. Beetles also develops tools that help organizations evaluate threats to their applications and web-facing domains, enabling them to safeguard their digital assets from potential cyber threats.

cWork Microjob Limited

Pre Seed Round in 2018
cWork is a mobile app based microjob platform, where the software as a service (SaaS) slices a big task into many small tasks and those task is done by thousands micro workers. We offer low cost microjob platform for data mining, web scraping machine learning, AI training data and captcha solving.

Zantrik

Pre Seed Round in 2018
Zantrik Limited is a vehicle maintenance service provider based in Dhaka, Bangladesh, established in 2018. The company has developed a mobile application that streamlines vehicle maintenance by offering a range of services, including roadside assistance, mechanical repairs, car cleaning, LPG conversion, car insurance, engine servicing, cylinder re-testing, and air conditioning servicing. Zantrik aims to address the fragmented and opaque nature of traditional vehicle maintenance by creating a connected platform that enhances transparency and convenience for vehicle owners, garages, and suppliers. The platform automates the entire maintenance process, from service requests to delivery, ensuring that all stakeholders have clear visibility and can achieve value for money. By leveraging technology and artificial intelligence, Zantrik seeks to establish a scalable solution that can be expanded across different regions.

RenaMed Biologics

Venture Round in 2006
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.

ViaCyte

Venture Round in 2006
ViaCyte, Inc. is a regenerative medicine company based in San Diego, California, focused on developing innovative cell replacement therapies for diabetes. The company is working on several product candidates, including VC-01, designed for type 1 diabetes, and VC-02, which facilitates blood vessel interaction with implanted pancreatic precursor cells. Their VCTX210 product utilizes a proprietary human stem cell line that helps prevent immune system rejection, eliminating the need for immunosuppressants. ViaCyte's therapies differentiate stem cells into pancreatic beta-cell precursors that are implanted in an encapsulation device, enabling the production of insulin in response to blood glucose levels. The company's aim is to provide long-term solutions for both type 1 and type 2 diabetes patients, reducing their dependence on insulin and minimizing associated health complications. Founded in 1999 and formerly known as Novocell, Inc., ViaCyte also has operations in Athens, Georgia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.